Shounan Lu

878 total citations
30 papers, 499 citations indexed

About

Shounan Lu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Shounan Lu has authored 30 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Cancer Research and 8 papers in Surgery. Recurrent topics in Shounan Lu's work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (10 papers) and MicroRNA in disease regulation (8 papers). Shounan Lu is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (10 papers) and MicroRNA in disease regulation (8 papers). Shounan Lu collaborates with scholars based in China, Japan and United States. Shounan Lu's co-authors include Sheng Tai, Zhilei Su, Wen Fu, Xingming Jiang, Zhifa Liu, Yong Ma, Chaoqun Wang, Zihao Li, Yanan Xu and Menghua Zhou and has published in prestigious journals such as Nature Communications, Oncogene and Scientific Reports.

In The Last Decade

Shounan Lu

25 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shounan Lu China 10 335 324 71 62 49 30 499
Xiaobo Yu China 11 317 0.9× 229 0.7× 97 1.4× 57 0.9× 58 1.2× 14 472
Yunpeng Jin China 10 406 1.2× 339 1.0× 63 0.9× 76 1.2× 32 0.7× 29 514
Jindan Luo China 13 444 1.3× 332 1.0× 65 0.9× 83 1.3× 86 1.8× 42 604
Songming Ding China 12 335 1.0× 231 0.7× 127 1.8× 62 1.0× 72 1.5× 20 510
Shikai Zhu China 14 341 1.0× 211 0.7× 159 2.2× 80 1.3× 81 1.7× 30 546
Jinsei Miyoshi Japan 8 312 0.9× 196 0.6× 76 1.1× 75 1.2× 46 0.9× 17 434
Junqing Hou China 11 292 0.9× 280 0.9× 58 0.8× 35 0.6× 85 1.7× 25 428
Xiao Xie China 14 350 1.0× 265 0.8× 67 0.9× 54 0.9× 47 1.0× 30 466
Yunong Fu China 12 358 1.1× 307 0.9× 67 0.9× 34 0.5× 118 2.4× 16 479

Countries citing papers authored by Shounan Lu

Since Specialization
Citations

This map shows the geographic impact of Shounan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shounan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shounan Lu more than expected).

Fields of papers citing papers by Shounan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shounan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shounan Lu. The network helps show where Shounan Lu may publish in the future.

Co-authorship network of co-authors of Shounan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Shounan Lu. A scholar is included among the top collaborators of Shounan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shounan Lu. Shounan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chaoqun, Shounan Lu, Yanan Xu, et al.. (2025). Arsenic trioxide preconditioning attenuates hepatic ischemia- reperfusion injury in mice: Role of ERK/AKT and autophagy. Chinese Medical Journal. 138(22). 2993–3003.
2.
Wang, Chaoqun, Baolin Qian, Bing Yin, et al.. (2025). GRINA alleviates hepatic ischemia‒reperfusion injury-induced apoptosis and ER-phagy by enhancing HRD1-mediated ATF6 ubiquitination. Journal of Hepatology. 83(1). 131–145. 5 indexed citations
3.
Qian, Baolin, Bing Yin, Chaoqun Wang, et al.. (2025). Axin formation inhibitor 1 aggravates hepatic ischemia‒reperfusion injury by promoting the ubiquitination and degradation of PPARβ. Nature Communications. 16(1). 1776–1776. 3 indexed citations
4.
Zhou, Yongzhi, Bing Yin, Yang Yang, et al.. (2025). Identifying shared hub genes in LIRI and MASLD through bioinformatics analysis and machine learning. Scientific Reports. 15(1). 18532–18532. 1 indexed citations
5.
Wang, Chaoqun, Yanan Xu, Shounan Lu, et al.. (2024). An integrative pan-cancer analysis of MASP1 and the potential clinical implications for the tumor immune microenvironment. International Journal of Biological Macromolecules. 280(Pt 3). 135834–135834. 4 indexed citations
6.
Li, Xinglong, Shounan Lu, Bing Yin, et al.. (2024). A comprehensive analysis of m6A/m7G/m5C/m1A-related gene expression and immune infiltration in liver ischemia–reperfusion injury by integrating bioinformatics and machine learning algorithms. European journal of medical research. 29(1). 326–326. 2 indexed citations
7.
Lu, Shounan, Yanan Xu, Bing Yin, et al.. (2024). RGS19 activates the MYH9/β-catenin/c-Myc positive feedback loop in hepatocellular carcinoma. Experimental & Molecular Medicine. 56(6). 1412–1425. 4 indexed citations
8.
Li, Xinglong, Bing Yin, Shounan Lu, et al.. (2024). Genome-wide analysis of alternative splicing differences in hepatic ischemia reperfusion injury. Scientific Reports. 14(1). 31349–31349.
9.
Zhou, Menghua, Shounan Lu, Chaoqun Wang, et al.. (2024). IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18/STAT3 pathway. Cancer Science. 115(3). 777–790. 10 indexed citations
10.
Li, Zhongyu, Shounan Lu, Baolin Qian, et al.. (2023). Sex differences in hepatic ischemia‒reperfusion injury: a cross-sectional study. Scientific Reports. 13(1). 5724–5724. 6 indexed citations
11.
Wang, Chaoqun, Shounan Lu, Yanan Xu, et al.. (2023). RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway. Oncogene. 42(24). 2017–2030. 10 indexed citations
12.
Xu, Yanan, Shounan Lu, Chaoqun Wang, et al.. (2023). HLTF promotes hepatocellular carcinoma progression by enhancing SRSF1 stability and activating ERK/MAPK pathway. Oncogenesis. 12(1). 2–2. 9 indexed citations
13.
Li, Xinglong, Bing Yin, Jingjing Huang, et al.. (2023). Comprehensive analysis of transcriptome‐wide M 6 A methylation for hepatic ischaemia reperfusion injury in mice. Epigenetics. 18(1). 2201716–2201716. 5 indexed citations
14.
Lu, Shounan, Chaoqun Wang, Yanan Xu, et al.. (2022). NNMT promotes the progression of intrahepatic cholangiocarcinoma by regulating aerobic glycolysis via the EGFR-STAT3 axis. Oncogenesis. 11(1). 39–39. 28 indexed citations
15.
Xu, Yanan, Xinglong Li, Bing Yin, et al.. (2022). Integrative analysis of the roles of lncRNAs and mRNAs in ischaemic preconditioning to alleviate liver ischaemia–reperfusion injury in mice. Biochemical and Biophysical Research Communications. 627. 30–38.
16.
Xu, Yanan, Yue Yu, Shounan Lu, et al.. (2022). Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets. Frontiers in Immunology. 13. 964891–964891. 7 indexed citations
17.
Ma, Mingjun, et al.. (2022). A SLC31A1-MEK-DNMT1-miR-124 feedback loop contributes to pancreatic cancer progression. Genes & Diseases. 10(3). 654–656. 2 indexed citations
18.
Zhou, Menghua, Chaoqun Wang, Shounan Lu, et al.. (2021). Tumor-associated macrophages in cholangiocarcinoma: complex interplay and potential therapeutic target. EBioMedicine. 67. 103375–103375. 43 indexed citations
19.
Wang, Chaoqun, et al.. (2021). Modified Laparoscopic Percutaneous Extraperitoneal Closure Using a Sledge-Shaped Needle for Inguinal Hernia and Hydrocele in 1199 Pediatric Patients. Journal of Laparoendoscopic & Advanced Surgical Techniques. 32(1). 96–101.
20.
Su, Zhilei, Shounan Lu, Wen Fu, et al.. (2018). LncRNA HOXA-AS2 and its molecular mechanisms in human cancer. Clinica Chimica Acta. 485. 229–233. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026